KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medtronic (MDT) Operating Expenses (2016 - 2026)

Medtronic's Operating Expenses history spans 14 years, with the latest figure at $3.8 billion for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 9.32% to $3.8 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $14.6 billion, a 4.01% increase, with the full-year FY2025 number at $13.8 billion, up 1.1% from a year prior.
  • Operating Expenses hit $3.8 billion in Q1 2026 for Medtronic, up from $3.7 billion in the prior quarter.
  • Over the last five years, Operating Expenses for MDT hit a ceiling of $3.8 billion in Q1 2026 and a floor of $3.3 billion in Q3 2022.
  • Historically, Operating Expenses has averaged $3.5 billion across 5 years, with a median of $3.4 billion in 2023.
  • Biggest five-year swings in Operating Expenses: dropped 5.05% in 2025 and later increased 9.32% in 2026.
  • Tracing MDT's Operating Expenses over 5 years: stood at $3.3 billion in 2022, then increased by 3.04% to $3.4 billion in 2023, then rose by 1.75% to $3.5 billion in 2024, then grew by 7.12% to $3.7 billion in 2025, then increased by 0.62% to $3.8 billion in 2026.
  • Business Quant data shows Operating Expenses for MDT at $3.8 billion in Q1 2026, $3.7 billion in Q4 2025, and $3.6 billion in Q3 2025.